1. Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small- Cell Lung Cancer 
Jeremy M. Kilburn, MD, Scott C. Lester, BS, John T. Lucas, MS, MD, Michael H. Soike, BS, A. William Blackstock, MD, William T. Kearns, MS, William H. Hinson, PhD, Antonius A. Miller, MD, William J. Petty, MD, Michael T. Munley, PhD, James J. Urbanic, MD 
Journal of Thoracic Oncology 
Volume 9, Issue 4, Pages (April 2014)
DOI: /JTO
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Illustration of initial treatment, salvage treatment, and composite radiation plan. ITV, internal target volume; PTV, planning target volume.
Journal of Thoracic Oncology 2014 9, DOI: ( /JTO )
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Kaplan–Meier estimates for distant control (A), PFS (B) from time of isolated mediastinal failure, and overall survival from the time of isolated mediastinal failure and from initial treatment (C). All progression events within 3 years were distant; therefore, the distant control and PFS curves are identical. PFS, progression-free survival.
Journal of Thoracic Oncology 2014 9, DOI: ( /JTO )
Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions